Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) EBIT (2016 - 2025)

HealthLynked (HLYK) has disclosed EBIT for 10 consecutive years, with -$735503.0 as the latest value for Q4 2025.

  • Quarterly EBIT fell 127.85% to -$735503.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.1 million through Dec 2025, down 139.69% year-over-year, with the annual reading at -$688900.0 for FY2025, 46.5% up from the prior year.
  • EBIT for Q4 2025 was -$735503.0 at HealthLynked, roughly flat from -$736654.0 in the prior quarter.
  • The five-year high for EBIT was $2.6 million in Q4 2024, with the low at -$4.1 million in Q4 2022.
  • Average EBIT over 5 years is -$968584.4, with a median of -$1.1 million recorded in 2023.
  • The sharpest move saw EBIT plummeted 422.58% in 2022, then skyrocketed 337.49% in 2024.
  • Over 5 years, EBIT stood at $1.3 million in 2021, then tumbled by 422.58% to -$4.1 million in 2022, then soared by 73.2% to -$1.1 million in 2023, then skyrocketed by 337.49% to $2.6 million in 2024, then crashed by 127.85% to -$735503.0 in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$735503.0, -$736654.0, and -$682780.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.